admin

On May 13th, 2024, Dr. Wu’s team published an article on Nature Medicine titled “Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer”. This original study suggests that there is an association between emotional distress and immunotherapy resistance in non-small-cell lung cancer, and proposes a new model to predict the […]

In the latest committee election held by the International Association for the Study of Lung Cancer (IASLC), Professor Wu Fang from our hospital has been appointed as a member of the Staging and Prognostic Factors Group (SPFG). This appointment recognizes her significant contributions to lung cancer staging and treatment. As part of her new role,